Novel polyethylene glycol derivative suitable for the preparation of mono-PEGylated protein

Biotechnology Letters

Volumn 27, Issue 3, 2005, Pages 213-217

  Yun, Qiang ^a   Chen, Ting ^b   Zhang, Guifeng ^a   Bi, Jingxiu ^a   Ma, Guanghui ^a   Su, Zhiguo ^a  

^a INSTITUTE OF PROCESS ENGINEERING   (China)

^b UNIVERSITY OF SCIENCE AND TECHNOLOGY BEIJING   (China)

Author keywords

Consensus interferon; Granulocyte colony stimulating factor; PEGylation; Polyethylene glycol

Indexed keywords

BIOLOGICAL ACTIVITIES; INTERFERON; MPEG; REACTIVE GROUPS;

CHARACTERIZATION; DERIVATIVES; MASS SPECTROMETRY; PROTEINS; SIZE EXCLUSION CHROMATOGRAPHY; SYNTHESIS (CHEMICAL); TOLUENE;

POLYETHYLENE GLYCOLS;

MACROGOL DERIVATIVE; MONOMETHOXYPOLYETHYLENE GLYCOL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT INTERFERON; RECOMBINANT PROTEIN;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; GEL CHROMATOGRAPHY; HUMAN; ISOLATION AND PURIFICATION; MASS SPECTROMETRY; MOLECULAR WEIGHT; SYNTHESIS;

CHROMATOGRAPHY, GEL; GRANULOCYTE COLONY STIMULATING FACTOR, RECOMBINANT; HUMANS; INTERFERON TYPE I, RECOMBINANT; MOLECULAR STRUCTURE; MOLECULAR WEIGHT; POLYETHYLENE GLYCOLS; RECOMBINANT PROTEINS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 17644396397     PISSN: 01415492     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10529-004-8354-7     Document Type: Article

References (16)

1. A Abuchowski JR McCoy NC Palczuk VE Theo FF Davis 1977 Effect of covalent attachment of poly(ethylene glycol) on immunogenicity and circulating life of bovine liver catalase J. Biol. Chem. 252 3582 3586
2. P Bailon A Palleroni CA Schaffer 2001 Rational design of a potent, long-lasting form of interferon: a 40 kDa-branched polyethylene glycol-conjugated interferon alpha-2a for the treatment of hepatitis C Bioconj. Chem. 12 195 202
3. I Benhar Q Wang D Fitzgerald I Pastan 1994 Pseudomonas exotoxin A mutants: replacement of surface exposed residues in domain III with cysteine residues that can be modified with polyethylene glycol in a site-specific manner J. Biol. Chem. 269 13398 13404
4. LM Blatt JM Davis SB Klein MW Taylor 1996 The biologic activity and molecular characterization of a novel synthetic interferon-alpha species-Consensus Interferon J. Interferon Cytokine Res. 16 489 499
5. P Esposito L Barbero P Caccia P Caliceti MD Antonio G Piquet FM Veronese 2003 PEGylation of growth hormone-releasing hormone (GRF) analogues Adv. Drug Deliv. Rev. 55 1279 1291
6. R Forti S Schuffman H Davies M Mitchell 1986 Objective antiviral assay of the interferons by computer assisted data collection and analysis Meth. Enzymol. 119 533 540
7. JM Harris FM Veronese 2003 Peptide and protein pegylation II-clinical evaluation Adv. Drug Deliv. Rev. 55 1259 1260
8. O Kinstler G Molineux M Treuheit D Ladd C Gegg 2002 Mono-N-terminal poly(ethylene glycol)-protein conjugates Adv. Drug Deliv. Rev. 54 477 485
9. S Naoki A Shigetaka M Satoru 1989 A new bioassay for human granulocyte colony stimulating factor (hG-CSF) using muring myeloblastic NFS-60 cells as targets and estimation of its levels in sera from normal health persons and patients with infections and hematological disorders J. Exp. Hematol. 17 116 119
10. DK Pettit WR Gombotz 1998 The development of site-specific drug-delivery systems for protein and peptides biopharmceuticals Trends Biotechnol. 16 343 349
11. JE Seely CW Richey 2001 Use of ion-exchange chromatography and hydrophobic interaction chromatography in the preparation and recovery of polyethylene glycol-linked proteins J. Chromatogr. 908 235 241
12. J Snider C Neville LC Yuan J Bullock 1992 Characterization of the heterogeneity of polyethylene glycol-modified superoxide dismutase by chromatographic and electrophoretic techniques J. Chromatogr. 599 141 155
13. LM Souza TC Boone J Gabrilove PH Lai KM Zsebo DC Murdock VR Chazin J Bruszewski H Lu KK Chen J Barendt E Platzer MAS Moore R Mertelsmann K Welte 1986 Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells Science 232 61 65
14. T Uchio M Baudys F Liu SC Song SW Kim 1999 Site-specific insulin conjugates with enhanced stability and extended action profile Adv. Drug Deliv. Rev. 35 289 306
15. FM Veronese 2001 Peptide and protein PEGylation: a review of problems and solutions Biomaterials 22 405 417
16. FM Veronese JM Harris 2002 Introduction and overview of peptide and protein pegylation Adv. Drug Deliv. Rev. 54 453 456